Supplementary Data 6 from The Mutational Landscape of Cancer's Vulnerability to Ionizing Radiation

Supplementary Data 6 from The Mutational Landscape of Cancer's Vulnerability to Ionizing Radiation

<p>Supplementary Data 6: Association between individual metabolites and radiation survival</p>

Збережено в:

Бібліографічні деталі
Автор:	Priyanka Gopal (15050862) (author)
Інші автори:	Brian D. Yard (15050865) (author), Aaron Petty (15050868) (author), Jessica C. Lal (15050871) (author), Titas K. Bera (15050874) (author), Trung Q. Hoang (15050877) (author), Alexandru D. Buhimschi (15050880) (author), Mohamed E. Abazeed (14936313) (author)
Опубліковано:	2025
Предмети:	Cancer Cancer Detection and Diagnosis Methods and Technology Biomarkers Genetic biomarkers Computational Methods Algorithms Gene Technologies Mutation detection methods Lung Cancer
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!

Схожі ресурси

Supplementary Data 1 from The Mutational Landscape of Cancer's Vulnerability to Ionizing Radiation
за авторством: Priyanka Gopal (15050862)
Опубліковано: (2025)

Supplementary Data 2 from The Mutational Landscape of Cancer's Vulnerability to Ionizing Radiation
за авторством: Priyanka Gopal (15050862)
Опубліковано: (2025)

Supplementary Data 3 from The Mutational Landscape of Cancer's Vulnerability to Ionizing Radiation
за авторством: Priyanka Gopal (15050862)
Опубліковано: (2025)

Supplementary Data 4 from The Mutational Landscape of Cancer's Vulnerability to Ionizing Radiation
за авторством: Priyanka Gopal (15050862)
Опубліковано: (2025)

Supplementary Data 5 from The Mutational Landscape of Cancer's Vulnerability to Ionizing Radiation
за авторством: Priyanka Gopal (15050862)
Опубліковано: (2025)

Supplementary Figure S6 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation
за авторством: Leon J. Wils (15055780)
Опубліковано: (2025)

Supplementary Table S7 from Gene Fusion Detection and Characterization in Long-Read Cancer Transcriptome Sequencing Data with FusionSeeker
за авторством: Yu Chen (14962271)
Опубліковано: (2025)

Supplementary Figure S1 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation
за авторством: Leon J. Wils (15055780)
Опубліковано: (2025)

Supplementary Figure S10 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation
за авторством: Leon J. Wils (15055780)
Опубліковано: (2025)

Supplementary Figure S11 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation
за авторством: Leon J. Wils (15055780)
Опубліковано: (2025)

Supplementary Figure S12 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation
за авторством: Leon J. Wils (15055780)
Опубліковано: (2025)

Supplementary Figure S2 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation
за авторством: Leon J. Wils (15055780)
Опубліковано: (2025)

Supplementary Figure S4 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation
за авторством: Leon J. Wils (15055780)
Опубліковано: (2025)

Supplementary Figure S5 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation
за авторством: Leon J. Wils (15055780)
Опубліковано: (2025)

Supplementary Figure S7 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation
за авторством: Leon J. Wils (15055780)
Опубліковано: (2025)

Supplementary Figure S8 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation
за авторством: Leon J. Wils (15055780)
Опубліковано: (2025)

Supplementary Figure S9 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation
за авторством: Leon J. Wils (15055780)
Опубліковано: (2025)

Supplementary Table S1 from Immunostimulatory Cancer-Associated Fibroblast Subpopulations Can Predict Immunotherapy Response in Head and Neck Cancer
за авторством: Aleksandar Obradovic (7549517)
Опубліковано: (2025)

Supplementary Table S2 from Immunostimulatory Cancer-Associated Fibroblast Subpopulations Can Predict Immunotherapy Response in Head and Neck Cancer
за авторством: Aleksandar Obradovic (7549517)
Опубліковано: (2025)

Supplementary Figure S1 from Association of Antifolate Response Signature Status and Clinical Activity of Pemetrexed-Platinum Chemotherapy in Non–Small Cell Lung Cancer: The Piedmont Study
за авторством: Joel R. Eisner (15132120)
Опубліковано: (2025)

Supplementary Figure S2 from Association of Antifolate Response Signature Status and Clinical Activity of Pemetrexed-Platinum Chemotherapy in Non–Small Cell Lung Cancer: The Piedmont Study
за авторством: Joel R. Eisner (15132120)
Опубліковано: (2025)

Supplementary Table S2 from Association of Antifolate Response Signature Status and Clinical Activity of Pemetrexed-Platinum Chemotherapy in Non–Small Cell Lung Cancer: The Piedmont Study
за авторством: Joel R. Eisner (15132120)
Опубліковано: (2025)

Figure S1 from <i>De Novo</i> and Histologically Transformed Small-Cell Lung Cancer Is Sensitive to Lurbinectedin Treatment Through the Modulation of EMT and NOTCH Signaling Pathways
за авторством: Subhamoy Chakraborty (16648124)
Опубліковано: (2025)

Figure S2 from <i>De Novo</i> and Histologically Transformed Small-Cell Lung Cancer Is Sensitive to Lurbinectedin Treatment Through the Modulation of EMT and NOTCH Signaling Pathways
за авторством: Subhamoy Chakraborty (16648124)
Опубліковано: (2025)

Figure S3 from <i>De Novo</i> and Histologically Transformed Small-Cell Lung Cancer Is Sensitive to Lurbinectedin Treatment Through the Modulation of EMT and NOTCH Signaling Pathways
за авторством: Subhamoy Chakraborty (16648124)
Опубліковано: (2025)

Supplementary Tables 1-3 from <i>De Novo</i> and Histologically Transformed Small-Cell Lung Cancer Is Sensitive to Lurbinectedin Treatment Through the Modulation of EMT and NOTCH Signaling Pathways
за авторством: Subhamoy Chakraborty (16648124)
Опубліковано: (2025)

Figure 6 from Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group
за авторством: David Milewski (15050643)
Опубліковано: (2025)

Supplementary Figure S6 from Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 Trial
за авторством: Tobias Kessler (17079209)
Опубліковано: (2025)

TS1-9 from Dynamics of Sequence and Structural Cell-Free DNA Landscapes in Small-Cell Lung Cancer
за авторством: Lavanya Sivapalan (15314248)
Опубліковано: (2025)

Supplementary Tables S1-S10 from <i>ACTA2</i> Expression Predicts Survival and Is Associated with Response to Immune Checkpoint Inhibitors in Gastric Cancer
за авторством: Sunho Park (15053897)
Опубліковано: (2025)

Figure 1 from Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group
за авторством: David Milewski (15050643)
Опубліковано: (2025)

Figure 2 from Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group
за авторством: David Milewski (15050643)
Опубліковано: (2025)

Figure 3 from Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group
за авторством: David Milewski (15050643)
Опубліковано: (2025)

Figure 4 from Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group
за авторством: David Milewski (15050643)
Опубліковано: (2025)

Figure 5 from Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group
за авторством: David Milewski (15050643)
Опубліковано: (2025)

Supplementary Table S1-S3 from Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group
за авторством: David Milewski (15050643)
Опубліковано: (2025)

Supplementary Figure S1 from Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 Trial
за авторством: Tobias Kessler (17079209)
Опубліковано: (2025)

Supplementary Figure S2 from Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 Trial
за авторством: Tobias Kessler (17079209)
Опубліковано: (2025)

Supplementary Figure S3 from Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 Trial
за авторством: Tobias Kessler (17079209)
Опубліковано: (2025)

Supplementary Figure S4 from Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 Trial
за авторством: Tobias Kessler (17079209)
Опубліковано: (2025)

Cannot write session to /tmp/vufind_sessions/sess_at2vaj26godrtovnc3cb7sa08m